Dr. Tomlinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Hematology and Oncology
Cleveland, OH 44106Phone+1 216-844-3951Fax+1 216-844-5759- Is this information wrong?
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
Case Western Reserve University School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - Present
OH State Medical License 2015 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies Start of enrollment: 2020 Nov 16
Roles: Contact, Sponsor-Investigator
- Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant Start of enrollment: 2024 Apr 01
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.Leland L Metheny, Ronald Sobecks, Christina Cho, Pingfu Fu, Seunghee Margevicius, Jiasheng Wang, Lisa Ciarrone, Shelby Kopp, Robin D Convents, Navneet Majhail, Paolo F...> ;Blood Advances. 2024 Mar 26
- 3 citationsGlasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.Mikkael A Sekeres, Pau Montesinos, Jan Novak, Jianxiang Wang, Deepa Jeyakumar, Benjamin Tomlinson, Jiri Mayer, Erin Jou, Tadeusz Robak, David C Taussig, Hervé Dombret,...> ;Leukemia. 2023 Oct 1
- 2 citationsUpdate on Small Molecule Targeted Therapies for Acute Myeloid Leukemia.Jiasheng Wang, Benjamin Tomlinson, Hillard M Lazarus> ;Current Treatment Options in Oncology. 2023 Jul 1
- Join now to see all
Abstracts/Posters
- Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-AzacytidineBenjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory LymphomasBenjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...Benjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Hospital Affiliations
University Hospitals Cleveland Medical CenterCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
